References
- Bernklev T, Jahnsen J, Henriksen M, Lygren I, Aadland E, Sauar J, et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 402–12
- Saverymuttu SH, Peters AM, Lavender JP, Pepys MB, Hodgson HJ, Chadwick VS. Quantitative faecal indium-111 labelled leucocyte excretion in assessment of disease activity in Crohn's disease. Gastroenterology 1983; 85: 1333–9
- Levenstein S, Prantera C, Varvo V, Scribano ML, Andreoli A, Luzi C, et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000; 95: 1213–20
- MacQueen G, Marshall J, Perdue M, Siegel S, Bienenstock J. Pavlovian conditioning of rat mucosal mast cells to protease II. Science 1989; 243: 83–5
- Soderholm JD, Yang PC, Ceponis P, Vohra A, Riddell R, Sherman PM, et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 2002; 123: 1099–8
- Santos J, Yang PC, Soderholm JD, Benjamin M, Perdue MH. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001; 48: 630–6
- Takeuchi K, Smale S, Premshand P, Maiden L, Sherwood R, Thjodleifsson B, et al. Prevalence and mechanism of NSAID-induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006; 4: 196–202
- Rampton DS, Sladen GE. Relapse of ulcerative proctocolitis during treatment with NSAIDs. Postgrad Med J 1981; 57: 297–9
- Bjarnason I, Macpherson AJM, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108: 1566–81
- Bridger S, Lee JC, Bjarnason I, Jones JE, Macpherson AJ. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis. Gut 2002; 51: 21–5
- Aldhous MC, Drummond HE, Anderson N, Smith LA, Arnott ID, JS. Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification. Am J Gastroenterol 2007; 102: 577–88
- Schroder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease: a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005; 100: 2503–9
- Erichsen K, Ulvik RJ, Nysaeter G, Johansen J, Ostborg J, Berstad A, et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 2005; 40: 1058–65
- Millan MS, Morris GP, Beck IT, Henson JT. Villous damage induced by suction biopsy and by acute ethanol intake in normal human small intestine. Dig Dis Sci 1980; 25: 513–25
- Foschi D, Marazzi M, Toti GL, Radaelli E, Ferrante F, Vaiani G, et al. Prostaglandin-stimulated recovery of the human duodenal epithelium: effects of misoprostol on ethanol damage. Am J Gastroenterol 1990; 85: 1498–1502
- Aabakken L. 51Cr ethylenediaminetetraacetic acid absorption test. Methodological aspects. Scand J Gastroenterol 1989; 24: 351–8
- Bjarnason I, Ward K, Peters TJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984; i: 179–82
- Bjarnason I, Takeuchi K, Bjarnason A, Adler SN, Teahon K. The G.U.T. of gut. Scand J Gastroenterol 2004; 39: 807–15
- Hey H, Schmedes A, Nielsen AA, Winding P, Grønbæk H. Effects of five different alcoholic drinks on patients with Crohn's disease. Scand J Gastroenterol 2007; 42: 968–972
- Mayberry JF, Rhodes J, Allan R, Newcombe RG, Regan GM, Chamberlain LM, et al. Diet in Crohn's disease: two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci 1981; 26: 444–8
- Bjarnason I, Batt R, Catt S, Macpherson A, Maxton D, Menzies IS. Evaluation of differential disaccharide excretion in urine for non-invasive assessment of intestinal disaccharidase activity caused by a-glucosidase inhibition, primary hypolactasia and coeliac disease. Gut 1996; 39: 374–81
- Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of Indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999; 34: 50–4